SCHEMBL23601732

SCHEMBL23601732

CC(C)(CCc1cccc(N(CC(F)F)c2nc3nncn3c3cccc(F)c23)c1)C(F)(F)F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23601449 0.92
SCHEMBL23601852 0.91 SMN1; SMN2 (0.31)
SCHEMBL23601969 0.85
SCHEMBL23601542 0.84
SCHEMBL23601436 0.83 CRY1 (0.31)
SCHEMBL23601460 0.82 TP53 (0.35)
SCHEMBL23601422 0.82
SCHEMBL23577263 0.82
SCHEMBL29909673 0.82
SCHEMBL23601681 0.82

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021130638-A1 DIACYLGLYCEROL KINASE MODULATING COMPOUNDS CARNA BIOSCIENCES, INC. (JP) 2021-07-01 WO disclosed